HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM was delisted on the 14th of June, 2023.
13 hedge funds and large institutions have $6.47M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 9 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
15% less capital invested
Capital invested by funds: $7.65M → $6.47M (-$1.18M)
41% less funds holding
Funds holding: 22 → 13 (-9)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$31.5K |
| 2 |
IF
Ironwood Financial
Tucson,
Arizona
|
+$3.99K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.2K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$617K |
| 2 |
BG
BlackRock Group
London,
United Kingdom
|
-$229K |
| 3 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$60K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$55.8K |
| 5 |
SAM
Securian Asset Management
St Paul,
Minnesota
|
-$32K |
HTGM Hedge Fund Activity: Q4 2016 in Review
13 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) for Q4 2016, worth a combined $6.47M — down 15% from $7.65M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of HTGM and 0 opened new positions — a net loss of 9 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $31.5K. The largest seller was BlackRock Advisors, exiting entirely with an estimated $617K sold.
- 13 institutional investors held HTG Molecular Diagnostics, Inc. Common Stock (HTGM) as of Q4 2016, down from 22 in Q3 2016.
- Funds reported $6.47M of HTG Molecular Diagnostics, Inc. Common Stock stock for Q4 2016, down 15% quarter-over-quarter.
- 0 funds opened new HTG Molecular Diagnostics, Inc. Common Stock positions in Q4 2016 and 9 closed out, a net change of -9 holders.
- The largest HTG Molecular Diagnostics, Inc. Common Stock buyer in Q4 2016 was Renaissance Technologies, an estimated $31.5K added.
- The largest HTG Molecular Diagnostics, Inc. Common Stock seller in Q4 2016 was BlackRock Advisors, an estimated $617K sold.
Based on aggregated 13F filings for Q4 2016.